EyePoint SEC filings: 8-K
Filter: All · 8-K · 10-Q · 10-K · Form 4
Results of operations and financial condition · Costs of exit or disposal activities · Other events · Financial statements and exhibits
AI summary, unreviewedEyePoint cuts 53% of workforce and ends wet AMD Phase 3 early after LUCIA miss, pivots to DME with ~$30 million annualized savings
Other events · Financial statements and exhibits
AI summary, unreviewedEyePoint's DURAVYU misses primary non-inferiority endpoint in LUCIA Phase 3 wet AMD trial, a second miss after LUGANO
Other events · Financial statements and exhibits
Other events · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits
Other events · Financial statements and exhibits